The untranslated exon B of human surfactant protein A2 mRNAs is an enhancer for transcription and translation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 301, Issue 5, 2011, Pages

  Silveyra, Patricia ^a   Raval, Manmeet ^a   Simmons, Brett ^a   Diangelo, Susan ^a   Wang, Guirong ^a   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cell specific regulatory factors; Secondary structure stability; Surfactant protein A; Trans binding sites; Untranslated regions

Indexed keywords

MESSENGER RNA; SURFACTANT PROTEIN A; SURFACTANT PROTEIN A2; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; EXON; EXON B; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PRIORITY JOURNAL; RNA TRANSLATION;

5' UNTRANSLATED REGIONS; ADENOCARCINOMA; ALTERNATIVE SPLICING; CELL LINE, TUMOR; EXONS; GENES, REPORTER; HUMANS; LUCIFERASES; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; PLASMIDS; PROTEIN BIOSYNTHESIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 80055107761     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00439.2010     Document Type: Article

References (53)

1. Andreassi C, Riccio A. To localize or not to localize: mRNA fate is in 3'UTR ends. Trends Cell Biol 19: 465-474, 2009.
2. Arnosti D, Kulkarni M. Transcriptional enhancers: intelligent enhanceosomes or flexible billboards? J Cell Biochem 94: 890-898, 2005.
3. Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27: 299-308, 1981.
4. Brasch F, Birzele J, Ochs M, Guttentag S, Schoch O, Boehler A, Beers M, Müller K, Hawgood S, Johnen G. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 24: 426-435, 2004.
5. Cheng G, Ueda T, Numao T, Kuroki Y, Nakajima H, Fukushima Y, Motojima S, Fukuda T. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J 16: 831-835, 2000.
6. deMello D, Heyman S, Phelps D, Floros J. Immunogold localization of SP-A in lungs of infants dying from respiratory distress syndrome. Am J Pathol 142: 1631-1640, 1993.
7. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, Floros J. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 15: 269-281, 1999.
8. Floros J. Human surfactant protein A (SP-A) variants: why so many, why such a complexity? Swiss Med Wkly 131: 87-90, 2001.
9. Floros J, Fan R, Matthews A, DiAngelo S, Luo J, Nielsen H, Dunn M, Gewolb IH, Koppe J, van Sonderen L, Farri-Kostopoulos L, Tzaki M, Ramet M, Merrill J. Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences. Clin Genet 60: 178-187, 2001.
10. Floros J, Wang G, Mikerov A. Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2- impact on function. Crit Rev Eukaryot Gene Expr 19: 125-137, 2009.
11. Gallie D, Tanguay R. Poly(A) binds to initiation factors and increases cap-dependent translation in vitro. J Biol Chem 269: 17166-17173, 1994.
12. García-Verdugo I, Wang G, Floros J, Casals C. Structural analysis and lipid-binding properties of recombinant human surfactant protein a derived from one or both genes. Biochemistry 41: 14041-14053, 2002.
13. Gebauer F, Hentze M. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol 5: 827-835, 2004.
14. Giri P, Kumar GS. Molecular aspects of small molecules-poly(A) interaction: an approach to RNA based drug design. Curr Med Chem 16: 965-987, 2009.
15. Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 36: W70-W74, 2008.
16. Hoover RR, Floros J. SP-A 3'-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol Lung Cell Mol Physiol 276: L917-L924, 1999.
17. Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 11: 113-127, 2010.
18. Jansen R. mRNA localization: message on the move. Nat Rev Mol Cell Biol 2: 247-256, 2001.
19. Karinch A, Deiter G, Ballard P, Floros J. Regulation of expression of human SP-A1 and SP-A2 genes in fetal lung explant culture. Biochim Biophys Acta 1398: 192-202, 1998.
20. Karinch A, Floros J. 5' Splicing and allelic variants of the human pulmonary surfactant protein A genes. Am J Respir Cell Mol Biol 12: 77-88, 1995.
21. Karinch AM, Floros J. Translation in vivo of 5' untranslated-region splice variants of human surfactant protein-A. Biochem J 307: 327-330, 1995.
22. Kida K, Oda H, Yamano Y, Kagawa J. Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A). Eur Respir J 10: 2124-2126, 1997.
23. Krizkova L, Sakthivel R, Olowe S, Rogan P, Floros J. Human SP-A: genotype and single-strand conformation polymorphism analysis. Am J Physiol Lung Cell Mol Physiol 266: L519-L527, 1994.
24. Kwon S, Barbarese E, Carson J. The cis-acting RNA trafficking signal from myelin basic protein mRNA and its cognate trans-acting ligand hnRNP A2 enhance cap-dependent translation. J Cell Biol 147: 247-256, 1999.
25. Le Quesne JP, Spriggs KA, Bushell M, Willis AE. Dysregulation of protein synthesis and disease. J Pathol 220: 140-151, 2010.
26. Liu Y, Wimmer E, Paul AV. Cis-acting RNA elements in human and animal plus-strand RNA viruses. Biochim Biophys Acta 1789: 495-517, 2009.
27. Maeda M, Kubo K, Nishi T, Futai M. Roles of gastric GATA DNAbinding proteins. J Exp Biol 199: 513-520, 1996.
28. Martineau Y, Derry MC, Wang X, Yanagiya A, Berlanga JJ, Shyu AB, Imataka H, Gehring K, Sonenberg N. Poly(A)-binding proteininteracting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation. Mol Cell Biol 28: 6658-6667, 2008.
29. McCormack FX, King TE Jr, Bucher BL, Nielsen L, Mason RJ. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 152: 751-759, 1995.
30. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 109: 707-712, 2002.
31. Mignone F, Gissi C, Liuni S, Pesole G. Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004, 2002.
32. Mikerov A, Umstead T, Gan X, Huang W, Guo X, Wang G, Phelps D, Floros J. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol 294: L121-L130, 2008.
33. Mikerov A, Umstead T, Huang W, Liu W, Phelps D, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 288: L150-L158, 2005.
34. Mikerov A, Wang G, Umstead T, Zacharatos M, Thomas N, Phelps D, Floros J. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun 75: 1403-1412, 2007.
35. Noah T, Murphy P, Alink J, Leigh M, Hull W, Stahlman M, Whitsett J. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein- D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 168: 685-691, 2003.
36. Nott A, Le Hir H, Moore MJ. Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev 18: 210-222, 2004.
37. Pavlovic J, Papagaroufalis C, Xanthou M, Liu W, Fan R, Thomas N, Apostolidou I, Papathoma E, Megaloyianni E, DiAngelo S, Floros J. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Dis Markers 22: 277-291, 2006.
38. Pesole G, Mignone F, Gissi C, Grillo G, Licciulli F, Liuni S. Structural and functional features of eukaryotic mRNA untranslated regions. Gene 276: 73-81, 2001.
39. Proudfoot NJ, Furger A, Dye MJ. Integrating mRNA processing with transcription. Cell 108: 501-512, 2002.
40. Rämet M, Haataja R, Marttila R, Floros J, Hallman M. Association between the surfactant protein A (SP-A) gene locus and respiratorydistress syndrome in the Finnish population. Am J Hum Genet 66: 1569-1579, 2000.
41. Seifart C, Lin H, Seifart U, Plagens A, DiAngelo S, von Wichert P, Floros J. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma. Clin Genet 68: 128-136, 2005.
42. Silveyra P, Wang G, Floros J. Human SP-A1 (SFTPA1) variant-specific 3' UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene. Am J Physiol Lung Cell Mol Physiol 299: L523-L534, 2010.
43. Staal FJ, Weerkamp F, Langerak AW, Hendriks RW, Clevers HC. Transcriptional control of t lymphocyte differentiation. Stem Cells 19: 165-179, 2001.
44. Tagaram H, Wang G, Umstead T, Mikerov A, Thomas N, Graff G, Hess J, Thomassen M, Kavuru M, Phelps D, Floros J. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol 292: L1052-L1063, 2007.
45. Thomas N, Fan R, Diangelo S, Hess J, Floros J. Haplotypes of the surfactant protein genes A and D as susceptibility factors for the development of respiratory distress syndrome. Acta Paediatr 96: 985-989, 2007.
46. Wang G, Bates-Kenney S, Tao J, Phelps D, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 43: 4227-4239, 2004.
47. Wang G, Guo X, Diangelo S, Thomas N, Floros J. Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. J Biol Chem 285: 11998-12010, 2010.
48. Wang G, Guo X, Floros J. Differences in the translation efficiency and mRNA stability mediated by 5'-UTR splice variants of human SP-A1 and SP-A2 genes. Am J Physiol Lung Cell Mol Physiol 289: L497-L508, 2005.
49. Wang G, Guo X, Floros J. Human SP-A 3'-UTR variants mediate differential gene expression in basal levels and in response to dexamethasone. Am J Physiol Lung Cell Mol Physiol 284: L738-L748, 2003.
50. Wang G, Guo X, Silveyra P, Kimball S, Floros J. Cap-independent translation of human SP-A 5'-UTR variants: a double-loop structure and cis-element contribution. Am J Physiol Lung Cell Mol Physiol 296: L635-L647, 2009.
51. Wang G, Myers C, Mikerov A, Floros J. Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants. Biochemistry 46: 8425-8435, 2007.
52. Wang G, Phelps D, Umstead T, Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF- production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 278: L946-L954, 2000.
53. Wang J, Reid K. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 212: 417-425, 2007.